Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance Formed to Digitalize Medicine and Healthcare

By LabMedica International staff writers
Posted on 28 Jun 2017
The Universitätsklinikum Erlangen, Siemens Healthineers (Erlangen, Germany), the Friedrich-Alexander-Universität-Erlangen-Nürnberg (FAU), the Fraunhofer Institute for Integrated Circuits (IIS), and Medical Valley EMN have entered into an alliance to establish the Digital Health Innovation Platform (d.hip) with the aim of driving digitalization in medicine and healthcare.

Founded in 1815, the Universitätsklinikum Erlangen covers all the areas of modern medicine with its 24 departments, 19 independent departments, and 7 institutes, and uses the latest knowledge from medical research and state-of-the-art equipment. More...
The FAU, founded in 1743, is one of the largest universities in Germany, with around 40,000 students, 263 degree programs, 4,000 academic staff in the sciences (including 576 professors), about 180 million euros (2016) in third-party funding, and 500 partnerships with universities around the world.

The Fraunhofer IIS is one of the world's leading application-oriented research institutions for microelectronic and IT system solutions and services. In close cooperation with partners and clients, it provides R&D services in various areas, including imaging systems and medical technology, among others. Medical Valley EMN e.V. has been operating as a cluster management organization since 2007 and currently comprises 190 members from the areas of business, academia, healthcare, networks, and politics. It undertakes a variety of functions, including the coordination of the “Digital Medicine/Health” platform as part of the Zentrum Digitalisierung Bayern (Bavarian Center for Digitalization), coordination of the “model region for digital healthcare management in Franconia” research initiative, and management of the “Digital Health Hub” as part of an initiative by the Federal Ministry for Economic Affairs. Siemens Healthineers, the separately managed healthcare business of Siemens AG, offers a comprehensive portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine.

The partners will be combining their medical, technical, and economical expertise to stimulate research into new areas and to conduct development so that it is even more interdisciplinary, clinically and scientifically relevant, and practice-oriented than ever. The platform will make it possible to implement innovations more efficiently and effectively, thereby reducing the time-to-market. The partners will also use their combined expertise to generate innovations. Among other things, machine learning will be used to render hospital procedures more efficient. For example, automated processes in clinical imaging can be tested that permit earlier diagnoses of breast cancer with a better detection rate. Methods for mathematical optimization and machine learning can help optimize the planning of operations, thus improving planning reliability.

Additionally, the partners see the integration of new technologies as having tremendous potential for improving medical care. “Clinical-grade wearables and sensor-based monitoring can promote a healthier lifestyle and improve treatment compliance or help to introduce adjustments to treatment early on. Intelligent image analysis methods for digital pathology can also support the selection and adjustment of individual treatments for tumor patients,” said Prof. Dr. Albert Heuberger, Director of the Fraunhofer Institute for Integrated Circuits IIS in Erlangen.

“Siemens Healthineers has committed itself to helping healthcare providers to overcome their current challenges and to continue their development in their particular business environment,” said Dr. Arthur Kaindl, General Manager of Digital Health Services, Siemens Healthineers. “We will contribute to d.hip our extensive expertise in the area of medical and laboratory technology and we want to make sure that our customers can use innovations in the field of digitalization as early as possible to improve medical patient care and reduce healthcare costs.”


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.